• Accueil >
  • Publications >
  • Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study

Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study

1 mai 2018Cancer/Radiothérapie

DOI : 10.1016/j.canrad.2017.10.004

Auteurs

A. Dautruche, L. Belin, P. Cottu, P. Bontemps, C. Lemanski, B. de la Lande, P. Baumann, F. Missohou, C. Lévy, K. Peignaux, A. Reynaud-Bougnoux, F. Denis, A. Gobillion, V. Pernin, Y. Kirova